This is not the most recent version of the article. View current version (16 FEB 2011)

Intervention Review

Treatment for Lambert-Eaton myasthenic syndrome

  1. Paul Maddison1,*,
  2. John Newsom-Davis2

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 27 FEB 2007

DOI: 10.1002/14651858.CD003279.pub2

How to Cite

Maddison P, Newsom-Davis J. Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD003279. DOI: 10.1002/14651858.CD003279.pub2.

Author Information

  1. 1

    Queen's Medical Centre, Department of Neurology, D Floor, West Block, Nottingham, UK

  2. 2

    (Deceased) Radcliffe Infirmary, , Department of Clinical Neurology, Oxford, UK

*Paul Maddison, Department of Neurology, D Floor, West Block, Queen's Medical Centre, Derby Road, Nottingham, NG7 2UH, UK. paul.maddison@nhs.net.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article.View current version (16 Feb 2011)

  1. Current Version

    Treatment for Lambert-Eaton myasthenic syndrome

    Michael Keogh, Saam Sedehizadeh and Paul Maddison

    Article first published online: 16 FEB 2011 | DOI: 10.1002/14651858.CD003279.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Treatment for Lambert-Eaton myasthenic syndrome

    Paul Maddison and John Newsom-Davis

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD003279.pub2

  2. Version 1

    Treatment for Lambert-Eaton myasthenic syndrome

    P Maddison and J Newsom-Davis

    Article first published online: 25 JAN 2005 | DOI: 10.1002/14651858.CD003279